David Carbone is a board-certified internal medicine physician with a sterling reputation for the development and use of novel therapeutics in the treatment of pleural mesothelioma.
- Director of the James Thoracic Center, James Cancer Hospital and Solove Research Institute.
- Expert in the molecular genetics of lung tumors, which includes understanding the cells and genetic markers in each patient’s lung cancer and developing treatments and drugs that target specific tumor cells.
- Research interests include genetics, immunotherapy, tumor-associated immunosuppression mechanisms, and targeted molecular gene therapy.
- Authored more than 200 peer-reviewed publications and review articles.
- Teaches at Ohio State University College of Medicine.
- Served on several National Cancer Institute grant review panels and now on its Board of Scientific Counselors.
- Served on organizing committees for both the American Society of Clinical Oncology and American Association for Cancer Research.
- Chair of Lung Biology subcommittee for the Eastern Cooperative Oncology Group.
- M.D. degree from Johns Hopkins University.
- Ph.D. degree from Johns Hopkins University.